137 related articles for article (PubMed ID: 27325138)
1. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
Arain F; Gullestad L; Nymo S; Kjekshus J; Cleland JG; Michelsen A; McMurray JJ; Wikstrand J; Aukrust P; Ueland T
Biomarkers; 2017; 22(3-4):261-267. PubMed ID: 27325138
[TBL] [Abstract][Full Text] [Related]
2. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Askevold ET; Gullestad L; Nymo S; Kjekshus J; Yndestad A; Latini R; Cleland JG; McMurray JJ; Aukrust P; Ueland T
PLoS One; 2015; 10(8):e0133970. PubMed ID: 26288364
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.
Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L;
Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Cleland JG; McMurray JJ; Kjekshus J; Cornel JH; Dunselman P; Fonseca C; Hjalmarson A; Korewicki J; Lindberg M; Ranjith N; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2009 Nov; 54(20):1850-9. PubMed ID: 19892235
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
6. Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.
Ueland T; Aukrust P; Nymo SH; Kjekshus J; McMurray JJ; Wikstrand J; Block D; Zaugg C; Gullestad L
J Card Fail; 2015 Feb; 21(2):153-9. PubMed ID: 25451704
[TBL] [Abstract][Full Text] [Related]
7. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
Feinstein MJ; Jhund P; Kang J; Ning H; Maggioni A; Wikstrand J; Kjekshus J; Tavazzi L; McMurray J; Lloyd-Jones DM
Eur J Heart Fail; 2015 Apr; 17(4):434-41. PubMed ID: 25684642
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; Adourian A; Böhm M; van Veldhuisen DJ; Komajda M; Cleland JG; Wikstrand J; McMurray JJ; Aukrust P;
Eur Heart J; 2012 Sep; 33(18):2290-6. PubMed ID: 22513778
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
van der Harst P; Slart RH; Tio RA; Dunselman PH; Willemsen AT; van den Heuvel AF; Voors AA; van Veldhuisen DJ;
Am J Cardiol; 2010 Feb; 105(4):517-21. PubMed ID: 20152247
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Rogers JK; Jhund PS; Perez AC; Böhm M; Cleland JG; Gullestad L; Kjekshus J; van Veldhuisen DJ; Wikstrand J; Wedel H; McMurray JJ; Pocock SJ
JACC Heart Fail; 2014 Jun; 2(3):289-97. PubMed ID: 24952697
[TBL] [Abstract][Full Text] [Related]
11. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Nymo SH; Ueland T; Askevold ET; Flo TH; Kjekshus J; Hulthe J; Wikstrand J; McMurray J; Van Veldhuisen DJ; Gullestad L; Aukrust P; Yndestad A
J Intern Med; 2012 May; 271(5):436-43. PubMed ID: 22211640
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.
Bonsu KO; Reidpath DD; Kadirvelu A
Cardiovasc Drugs Ther; 2016 Apr; 30(2):177-88. PubMed ID: 26780905
[TBL] [Abstract][Full Text] [Related]
14. Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure.
Nymo SH; Aukrust P; Kjekshus J; McMurray JJ; Cleland JG; Wikstrand J; Muntendam P; Wienhues-Thelen U; Latini R; Askevold ET; Gravning J; Dahl CP; Broch K; Yndestad A; Gullestad L; Ueland T;
JACC Heart Fail; 2017 Apr; 5(4):256-264. PubMed ID: 28359413
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
Haver VG; Mateo Leach I; Kjekshus J; Fox JC; Wedel H; Wikstrand J; de Boer RA; van Gilst WH; McMurray JJ; van Veldhuisen DJ; van der Harst P
Eur J Heart Fail; 2015 Mar; 17(3):313-9. PubMed ID: 25639660
[TBL] [Abstract][Full Text] [Related]
16. [To treat or not to treat with statins patients with chronic heart failure?].
Hradec J
Vnitr Lek; 2009 Sep; 55(9):802-7. PubMed ID: 19785380
[TBL] [Abstract][Full Text] [Related]
17. Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Askevold ET; Nymo S; Ueland T; Gravning J; Wergeland R; Kjekshus J; Yndestad A; Cleland JG; McMurray JJ; Aukrust P; Gullestad L
Circ Heart Fail; 2013 Jan; 6(1):91-8. PubMed ID: 23230311
[TBL] [Abstract][Full Text] [Related]
18. [Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].
Mareev VIu
Kardiologiia; 2008; 48(1):74-5. PubMed ID: 18261000
[No Abstract] [Full Text] [Related]
19. Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Perez-Moreno AC; Jhund PS; Macdonald MR; Petrie MC; Cleland JG; Böhm M; van Veldhuisen DJ; Gullestad L; Wikstrand J; Kjekshus J; Lewsey JD; McMurray JJ
JACC Heart Fail; 2014 Apr; 2(2):187-97. PubMed ID: 24720928
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).
Perez AC; Jhund PS; Stott DJ; Gullestad L; Cleland JG; van Veldhuisen DJ; Wikstrand J; Kjekshus J; McMurray JJ
JACC Heart Fail; 2014 Feb; 2(1):35-40. PubMed ID: 24622117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]